| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
| 05/16/2006 | US7045518 Compounds for treatment of AIDS with enzyme inhibitors |
| 05/11/2006 | WO2006048727A1 Piperazinylphenalkyl lactam/amine ligands for the 5ht1b receptor |
| 05/11/2006 | US20060100237 Excitatory amino acid receptor antagonists |
| 05/10/2006 | CN1769272A Tetrahydroisoquinoline derivative, its preparation method and pharmaceutical composition |
| 05/10/2006 | CN1769271A Decahydroisoquinoline preparation method |
| 05/09/2006 | US7041829 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 05/09/2006 | US7041681 Nitrogen heterocyclic compounds, e.g., 3-(2-oxo-2-phenyl-ethylcarbamoyl)-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester; treating pain and gastrointestinal disorders. |
| 05/09/2006 | US7041676 Compounds, compositions, and methods |
| 05/09/2006 | US7041354 Optical data carrier comprising a cyanine dye as light-absorbent compound in the information layer |
| 05/04/2006 | WO2005025681A3 A system for and a method of manufacturing personal golf putters |
| 05/04/2006 | US20060094743 Isoquinoline compounds and medicinal use thereof |
| 05/03/2006 | EP1652525A1 Anti-coronavirus drug |
| 05/03/2006 | EP1651595A2 Ubiquitin ligase inhibitors |
| 05/03/2006 | EP1651229A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 05/03/2006 | EP1465870B1 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 05/03/2006 | EP1311486B1 Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1099692B1 N,n-substituted cyclic amine derivatives |
| 05/03/2006 | CN1768040A Isoquinoline-5-sulfonic acid amides as inhibitors of AKT (protein kinase B) |
| 05/03/2006 | CN1768038A Using alkylmetal reagents for directed metalation of azaaromatics |
| 05/02/2006 | US7037942 Amide compounds for the potentiation of cholinergic activity |
| 05/02/2006 | US7037924 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors |
| 05/02/2006 | US7037913 Piperazinyl derivatives of naphthalenes, (iso)quinolines and naphthyridines; used particularly the treatment of HIV and AIDS. |
| 05/02/2006 | CA2250426C Amidinohydrazones as protease inhibitors |
| 04/27/2006 | US20060089379 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 04/27/2006 | CA2584507A1 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
| 04/26/2006 | EP1649871A1 Retroviral protease inhibitor combinations |
| 04/26/2006 | CN1764647A Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 04/26/2006 | CN1253440C New iso quinoline compound with HIV-1 resisting activity |
| 04/25/2006 | US7034052 Anticancer agents; inflammatory bowel disorders; myelodysplastic syndrome |
| 04/25/2006 | US7034039 Fused heterocyclic compounds |
| 04/25/2006 | US7034033 Substituted quinazolinone compounds |
| 04/20/2006 | WO2005113513A3 Aryl sulfonamides |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/19/2006 | EP1646659A2 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 04/19/2006 | EP1487801B1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo¬d|azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders |
| 04/19/2006 | EP1412331B1 Process for the production of 4-amino-2,5-bisheterocyclylquinazolines |
| 04/19/2006 | EP1353921B1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 04/18/2006 | US7030120 Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same |
| 04/18/2006 | US7029835 Photothermographic element comprising improved base precursors and methods for their use |
| 04/13/2006 | WO2006038594A1 N-type calcium channel inhibitor |
| 04/13/2006 | WO2005007621A3 Ubiquitin ligase inhibitors |
| 04/13/2006 | US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/12/2006 | EP1644367A1 Immunosuppressant compounds and compositions |
| 04/12/2006 | EP1644336A1 Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |
| 04/12/2006 | EP1644325A2 Methods and compositions for treating amyloid-related diseases |
| 04/12/2006 | EP1087981B1 Prenyl transferase inhibitors |
| 04/12/2006 | EP0903337B1 Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
| 04/12/2006 | CN1759120A Metal complexes |
| 04/12/2006 | CN1250528C Cyclic nitrones and pharmaceutical compositions containing them |
| 04/11/2006 | US7026485 inhibitors of HIV protease; N-heterocyclic moiety containing hydroxyethylamine compounds where the heterocyclic moiety may be octahydroisoquinoline |
| 04/11/2006 | US7026478 Iron catalyzed cross coupling reactions of aromatic compounds |
| 04/11/2006 | US7026333 Retroviral protease inhibitors |
| 04/11/2006 | CA2322558C Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| 04/11/2006 | CA2217030C Protease inhibiting succinic acid derivatives |
| 04/06/2006 | US20060074098 Methods of treatment of amyloidosis using ethanolcyclicamine aspartyl protease inhibitors |
| 04/06/2006 | US20060074087 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/05/2006 | EP1641760A2 Novel tetrahydroquinolines |
| 04/05/2006 | CN1756550A 2,5- and 2,6-substituted tetrahydroisoquinolines for use as 5-HT6 modulators |
| 04/05/2006 | CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 04/05/2006 | CN1249227C 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
| 04/05/2006 | CN1249055C Piperazinylcarbonylquinolines and -isoquinolines |
| 03/30/2006 | WO2006032372A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, their use as a medicament, and a medicament containing them |
| 03/30/2006 | WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 03/30/2006 | WO2004113330A8 Immunosuppressant compounds and compositions |
| 03/30/2006 | US20060069259 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus |
| 03/30/2006 | US20060069034 Antipathogenic benzamide compounds |
| 03/30/2006 | DE102004046492A1 Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament Substituted 4-Phenyltetrahydroisochinoline, processes for their preparation, their use as a medicament, and medicament containing them |
| 03/30/2006 | CA2580924A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, their use as a medicament, and a medicament containing them |
| 03/29/2006 | EP1640449A1 Cell differentiation inhibiting agent, cell culture method using the same, culture medium and cultured cell line |
| 03/29/2006 | EP1640367A1 Isoquinoline -1,3,4-trione, the synthetic method and the use thereof |
| 03/29/2006 | EP1638928A1 N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides |
| 03/29/2006 | EP1638565A2 Substituted piperidine compounds and methods of their use |
| 03/29/2006 | CN1247544C Anthranilic acid amides with heteroarylsulfonyl side chain and use thereof as active substance for antiarythmia |
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | US7018430 With novel pigment dyes based on naphthalimide; light-fast, thermostable, tinctorially strong colorations especially in the yellow color range; benzofuro(3,2-k)-7h-benzimidazo(2,1-a)benz(de)isoquinolin-7-one compounds |
| 03/28/2006 | CA2125104C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/23/2006 | WO2006030208A1 Amino acid |
| 03/23/2006 | WO2006030032A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 03/23/2006 | US20060063769 Preventives/remedies for urinary disturbance |
| 03/23/2006 | US20060063763 Compounds and methods for modulating CXCR3 function |
| 03/23/2006 | CA2581144A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 03/22/2006 | EP1637140A1 Use of diphenylmethylpiperazine derivatives for the manufacture of a medicament for suppressing the proliferation of fibroblasts |
| 03/22/2006 | EP1636159A1 Method for the treatment or prevention of lower urinary tract symptoms |
| 03/22/2006 | EP1139743B1 Exo-s-mecamylamine formulation and use in treatment |
| 03/21/2006 | US7015328 Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/21/2006 | US7015323 Resistant to metabolism having improved half-life and/or clearance properties compared to corresponding carbamate compounds; for example, N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; use to treat inflammatory diseases for example |
| 03/21/2006 | US7015233 Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor |
| 03/21/2006 | CA2124932C Sex steroid activity inhibitors |
| 03/16/2006 | WO2006002763A3 Substituted tetrahydroisochinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drags |
| 03/16/2006 | WO2005115361A3 Androgen receptor modulators and method of treating disease using the same |
| 03/16/2006 | US20060058548 Process of preparing O-carbamoyl compounds in the presence of active amine group |
| 03/16/2006 | US20060058396 Amide compounds for the potentiation of cholinergic activity |
| 03/16/2006 | US20060058362 7-Amido-isoindolyl compounds and methods of their use |
| 03/16/2006 | US20060058360 Heteroaryloxy/thio propanamines; improved acid stability, potency and selectivity to the dopamine transporter; improved ADME properties e.g. reduced tendency to act as a substrate and/or inhibitor the enzyme Cytochrome P450; pain; [(3R)-3-(Isoquinolin-4-yloxy)-3-phenyl-propyl]-methyl-amine hydrochloride |
| 03/16/2006 | US20060058347 high purity amorphous quinapril hydrochloride can be obtained specially free of diketopiperazine impurity |
| 03/16/2006 | US20060058346 Novel enantiomers of etrahydroisoquinoline derivatives and theirpharmaceutically acceptable salts, their preparations and pharmaceutical compositions |
| 03/15/2006 | EP1634498A2 Exo-S-mecamylamine formulation |
| 03/15/2006 | EP1633743A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |